HM13 and hepatocellular carcinoma: Here we show that the gamma-secretase and signal peptide peptidase (SPP) inhibitor LY411,575, but not the selective gamma-secretase inhibitor (GSI) DAPT, impairs development of P. berghei in vitro in hepatoma cells as well as in vivo in mouse liver.